ArticleScience (New York, N.Y.)2021

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.

Kris M White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.